Literature DB >> 7934632

Morphine and morphine metabolite kinetics in the rat brain as assessed by transcortical microdialysis.

M Barjavel1, P Sandouk, M Plotkine, J M Scherrmann.   

Abstract

Morphine (M), morphine 3-glucuronide (M3G) and morphine 6-glucuronide (M6G) were subcutaneously administered at 10 mg/kg in three groups of six awake rats. A transverse microdialysis probe was implanted in the brain cortex and dialysates were collected every 30 minutes for a period of 4 hours. Dialysates were measured by two different opiate radioimmunoassays. Maximum brain opiate concentrations, 41 +/- 10 ng/ml (M), 147 +/- 27 ng/ml (M3G), 177 +/- 43 ng/ml (M6G), were reached at the same Tmax, 0.75 h, and elimination half-lives ranged from 0.99 to 0.81 h for the 3 compounds. Kinetic parameters confirmed that penetration and elimination rates in the extracellular space of the rat brain cortex for the 2 hydrophilic M metabolites were similar to those of M. These results indicate for the first time that, in spite of their structural differences, glucuronide metabolites of M are capable of crossing the blood-brain-barrier (BBB) at the same rate as morphine does, but in higher amount.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7934632     DOI: 10.1016/0024-3205(94)90069-8

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

1.  Analgesic and immunomodulatory effects of codeine and codeine 6-glucuronide.

Authors:  V Srinivasan; D Wielbo; J Simpkins; J Karlix; K Sloan; I Tebbett
Journal:  Pharm Res       Date:  1996-02       Impact factor: 4.200

2.  Relationship between morphine analgesia and cortical extracellular fluid levels of morphine and its metabolites in the rat: a microdialysis study.

Authors:  M J Barjavel; J M Scherrmann; H N Bhargava
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

3.  Elevated concentrations of morphine 6-beta-D-glucuronide in brain extracellular fluid despite low blood-brain barrier permeability.

Authors:  F Stain-Texier; G Boschi; P Sandouk; J M Scherrmann
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

4.  Biovector nanoparticles improve antinociceptive efficacy of nasal morphine.

Authors:  D Betbeder; S Spérandio; J P Latapie; J de Nadai; A Etienne; J M Zajac; B Francés
Journal:  Pharm Res       Date:  2000-06       Impact factor: 4.200

5.  Microdialysis study of bromocriptine and its metabolites in rat pituitary and striatum.

Authors:  S Granveau-Renouf; D Valente; A Durocher; J M Grognet; E Ezan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2000 Apr-Jun       Impact factor: 2.569

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.